CELLREP Trademark

Trademark Overview


On Monday, June 2, 2025, a trademark application was filed for CELLREP with the United States Patent and Trademark Office. The USPTO has given the CELLREP trademark a serial number of 99213731. The federal status of this trademark filing is REGISTERED as of Tuesday, June 23, 2026. This trademark is owned by CellRep Corporation. The CELLREP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for for data analysis, drug discovery, drug screening, and preclinical testing in the field of bioinformatics; Research and development in the field of bioinformatics; Research and development in the field of cancer treatment and diagnosis; Drug discovery services; Drug screening for scientific research purposes; Testing of pharmaceuticals for cell and gene therapies; Research and development in the field of cell reprogramming technology for therapeutic applications; Research and development in the field of epigenomic modification for cellular medicine; Research and development in the field of enhancing cell and gene therapies; Research and development in the field of immune cell enhancement and rejuvenation; Research and development in the field of cell therapy enhancement for treatment of cancer, viral infections, and autoimmune disorders; Research and development in the field of therapeutic kits and solutions for cel...
cellrep

General Information


Serial Number99213731
Word MarkCELLREP
Filing DateMonday, June 2, 2025
Status700 - REGISTERED
Status DateTuesday, June 23, 2026
Registration Number8319087
Registration DateTuesday, June 23, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements


Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for for data analysis, drug discovery, drug screening, and preclinical testing in the field of bioinformatics; Research and development in the field of bioinformatics; Research and development in the field of cancer treatment and diagnosis; Drug discovery services; Drug screening for scientific research purposes; Testing of pharmaceuticals for cell and gene therapies; Research and development in the field of cell reprogramming technology for therapeutic applications; Research and development in the field of epigenomic modification for cellular medicine; Research and development in the field of enhancing cell and gene therapies; Research and development in the field of immune cell enhancement and rejuvenation; Research and development in the field of cell therapy enhancement for treatment of cancer, viral infections, and autoimmune disorders; Research and development in the field of therapeutic kits and solutions for cellular medicine; Platform as a service (PAAS) featuring computer software platforms for for enhancing cellular function and longevity; Consulting services in the field of pharmaceutical research; Consulting services in the field of biotechnology; Consulting services in the field of genetic science

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 2, 2025
Primary Code042
First Use Anywhere DateWednesday, August 7, 2024
First Use In Commerce DateWednesday, March 26, 2025

Trademark Owner History


Party NameCellRep Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBuenos Aires 1636
US

Party NameCellRep Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeunos Aires 1636
US

Party NameCellRep Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeunos Aires 1636
US

Trademark Events


Event DateEvent Description
Monday, June 2, 2025NEW APPLICATION ENTERED
Monday, June 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, October 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 21, 2025ASSIGNED TO EXAMINER
Tuesday, October 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 13, 2026NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 11, 2026TEAS STATEMENT OF USE RECEIVED
Wednesday, February 11, 2026USE AMENDMENT FILED
Tuesday, June 2, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 3, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 3, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 25, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 25, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 25, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED